. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AgedAspirin/administration & dosageAspirin/adverse effectsCerebrovascular Disorders/drug therapyCerebrovascular Disorders/mortalityCerebrovascular Disorders/prevention & controlData Interpretation, StatisticalDelayed-Action PreparationsDipyridamole/administration & dosageDipyridamole/adverse effectsDouble-Blind MethodFemaleHumansMaleMiddle AgedPatient CompliancePlacebosPlatelet Aggregation Inhibitors/administration & dosagePlatelet Aggregation Inhibitors/adverse effectsSafety
Substances: See more » Delayed-Action PreparationsPlacebosPlatelet Aggregation InhibitorsDipyridamoleAspirin
Year: 1997 PMID: 9276859 DOI: 10.1016/s0022-510x(97)86566-5
Source DB: PubMed Journal: J Neurol Sci ISSN: 0022-510X Impact factor: 3.181